PaulRayomndKunkMD
Hematology • Charlottesville, VAAssistant Professor of Medicine, Division of Hematology Oncology, University of Virginia
Dr. Kunk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1240 Lee St
Charlottesville, VA 22908Phone+1 434-924-9333Fax+1 434-243-6086
Summary
- Dr. Paul Kunk is a hematologist in Charlottesville, VA and is affiliated with University of Virginia Medical Center. He received his medical degree from University of Tennessee Health Science Center College of Medicine and has been in practice 6 years. He is experienced in gastrointestinal cancer, esophageal cancer, gallbladder cancer, pancreatic cancer, and stomach cancer.
Education & Training
University of VirginiaFellowship, 2014 - 2017
University of Virginia Medical CenterResidency, Internal Medicine, 2007 - 2011
University of Tennessee Health Science Center College of MedicineClass of 2011
Certifications & Licensure
FL State Medical License 2022 - 2026
DC State Medical License 2022 - 2024
NE State Medical License 2022 - 2024
VA State Medical License 2015 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Joseph H. Farrow Research Award University of Virginia
- Excellence in Clinical Medicine Award University of Virginia
- Staff Member of the Month San Jose State University
- Join now to see all
Clinical Trials
- Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements Start of enrollment: 2020 Mar 01
Roles: Contact
Publications & Presentations
PubMed
- Outcomes associated with total neoadjuvant therapy with non-operative intent for rectal adenocarcinoma.Ebenezer Asare, Emily Venner, Hanna Batchelor, Jason Sanders, Paul Kunk
Frontiers in Oncology. 2024-01-01 - 23 citationsARRY-382 in Combination with Pembrolizumab in Patients with Advanced Solid Tumors: Results from a Phase 1b/2 Study.Melissa Johnson, Arkadiusz Z Dudek, Ammar Sukari, Justin Call, Paul R Kunk
Clinical Cancer Research. 2022-06-13 - 4 citationsMyeloid Cell Infiltration Correlates With Prognosis in Cholangiocarcinoma and Varies Based on Tumor LocationPaul R. Kunk, Sean C. Dougherty, Kevin T. Lynch, Rachel Whitehair, Max O. Meneveau
Journal of Immunotherapy. 2021-09-01
Press Mentions
Your Blood Pressure & Heartburn Medicine Might Help You Survive Colon Cancer or COVIDJanuary 26th, 2022
Professional Memberships
- Member
- Member
- Member
- Phi Alpha Theta National Honors Society of HistoryMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
